In a different kind of heart donation, a Hearts in San Francisco sculpture has been given to the city of Vacaville, city ...

Imugene's trial programs could result in the first 'off the shelf' Car-T therapy that uses healthy donors' cells.

Oregon's bioscience sector has been growing faster than the overall economy, but proposed federal budget cuts could slow its ...

COUR Pharmaceuticals has been around a while, but not until last year did the company solidify behind its ultimate mission ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic macular edema (DME) who have previously responded to at least 2 ...

The U.S. Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for ...

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

Atomwise, a leader in leveraging machine learning and artificial intelligence (ML/AI) to advance small molecule drug discovery, today announced the appointment of Steve Worland, Ph.D. as Chief ...

The National Institutes of Health has lost two distinguished leaders as mass layoffs directed by the Trump administration hit federal health agencies.

Aadi Bioscience, Inc. (NASDAQ: AADI) today announced the appointment of David Dornan, PhD as the Company's Chief Scientific ...

Dr. Rousseau to lead clinical development as Pheast advances PHST001, a novel anti-CD24 macrophage checkpoint inhibitor, into clinical trials. PALO ALTO, Calif., February 18, 2025 ...

The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...